Apostol AI, Kotsopoulos J, Gronwald J, Kim RH, Karlan BY, Aeilts A, Cajal TRY, Pal T, Eisen A, Bordeleau L, Foulkes WD, Couch F, Zakalik D, Fruscio R, Sun P, Lubinski J, Tung N, Singer CF, Moller P, Dominguez-Valentin M, Narod SA, Metcalfe K, Hereditary Breast Cancer Clinical Study Group (2025)
Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant
201, 44-52
DOI 10.1016/j.ygyno.2025.07.030, PubMed 40784323
Campos-Segura AV, Alvarez K, Murillo Carrasco AG, Rossi BM, Bohorquez M, Spirandelli F, Benavides C, Balto A, Della Valle A, Bruno LI, Lopez-Kostner F, Cruz-Correa M, Del Monte JS, Rugeles J, Ramirez JM, Nascimento I, Forones NM, Cock-Rada AM, Reyes-Silva C, Avila S, Apolinario L, Rossi NT, Martin C, Sulcahuaman Y, Vaccaro CA et al. (2025)
Characterization of Screening Strategies for Lynch Syndrome in Latin America
23 (9), 1642-1654
DOI 10.1016/j.cgh.2024.12.026, PubMed 40010418
Kohut K, Morton K, Turner L, Foster R, Bancroft EK, Burn J, Crosbie EJ, Dominguez-Valentin M, Esplen MJ, Hanson H, Hurley K, Moller P, Ryan N, Snape K, CanGene‐CanVar Patient Reference Panel, International Lynch Decision Aid Stakeholder Panel, Eccles D, Foster C (2025)
Optimizing risk-reducing surgery and aspirin decision aids for Lynch syndrome carriers using the person-based approach: A think-aloud interview study
34 (4), e70089
DOI 10.1002/jgc4.70089, PubMed 40772451
Møller P, Ahadova A, Kloor M, Seppälä TT, Burn J, Haupt S, Macrae F, Dominguez-Valentin M, Möslein G, Lindblom A, Sunde L, Winship I, Capella G, Monahan K, Buchanan DD, Evans DG, Hovig E, Sampson JR (2025)
Colorectal carcinogenesis in the Lynch syndromes and familial adenomatous polyposis: trigger events and downstream consequences
23 (1), 3
DOI 10.1186/s13053-025-00305-y, PubMed 39849512
Møller P, Seppälä TT, Dominguez-Valentin M, Sampson J (2025)
Commentary on Estimating cancer risk in carriers of Lynch syndrome variants in UK Biobank
62 (2), 53
DOI 10.1136/jmg-2024-110385, PubMed 39375027
Akdeniz BC, Morris AH, Møller P, Andreassen O, Hovig E, Dominguez-Valentin M (2024)
Evaluation of a combined model of Polygenic Risk Score and mismatch repair genes in the association of colorectal cancer for Norwegian cohort
3008916241303648 (in press)
DOI 10.1177/03008916241303648, PubMed 39654342
Ivarsdottir EV, Gudmundsson J, Tragante V, Sveinbjornsson G, Kristmundsdottir S, Stacey SN, Halldorsson GH, Magnusson MI, Oddsson A, Walters GB, Sigurdsson A, Saevarsdottir S, Beyter D, Thorleifsson G, Halldorsson BV, Melsted P, Stefansson H, Jonsdottir I, Sørensen E, Pedersen OB, Erikstrup C, Bøgsted M, Pøhl M, Røder A, Stroomberg HV et al. (2024)
Gene-based burden tests of rare germline variants identify six cancer susceptibility genes
56 (11), 2422-2433
DOI 10.1038/s41588-024-01966-6, PubMed 39472694
Katona BW, Lubinski J, Pal T, Huzarski T, Foulkes WD, Moller P, Eisen A, Randall Armel S, Neuhausen SL, Raj R, Aeilts A, Singer CF, Bordeleau L, Karlan B, Olopade O, Tung N, Zakalik D, Kotsopoulos J, Fruscio R, Eng C, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group (2024)
The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation
131 (1), e35666
DOI 10.1002/cncr.35666, PubMed 39611336
Møller P, Haupt S, Ahadova A, Kloor M, Sampson JR, Sunde L, Seppälä T, Burn J, Bernstein I, Capella G, Evans DG, Lindblom A, Winship I, Macrae F, Katz L, Laish I, Vainer E, Monahan K, Half E, Horisberger K, da Silva LA, Heuveline V, Therkildsen C, Lautrup C, Klarskov LL et al. (2024)
Incidences of colorectal adenomas and cancers under colonoscopy surveillance suggest an accelerated "Big Bang" pathway to CRC in three of the four Lynch syndromes
22 (1), 6
DOI 10.1186/s13053-024-00279-3, PubMed 38741120
Møller P, Hovig E (2024)
Genetic testing for prevention and treatment of cancer
144 (13)
DOI 10.4045/tidsskr.24.0434, PubMed 39498653
van der Werf-'t Lam AS, Rodriguez-Girondo M, Villasmil M, Tops CM, van Hest L, Gille HJP, Duijkers FAM, Wagner A, Eikenboom E, Letteboer TGW, de Jong MM, Bajwa-Ten Broeke SW, Bleeker F, Gomez Garcia EB, Dominguez-Valentin M, Møller P, Suerink M, Nielsen M (2024)
Delineating genotype and parent-of-origin effect on the phenotype in MSH6-associated Lynch syndrome
63 (5), e23237
DOI 10.1002/gcc.23237, PubMed 38722212
Akdeniz BC, Mattingsdal M, Dominguez-Valentin M, Frei O, Shadrin A, Puustusmaa M, Saar R, Sõber S, Møller P, Andreassen OA, Padrik P, Hovig E (2023)
A Breast Cancer Polygenic Risk Score Is Feasible for Risk Stratification in the Norwegian Population
15 (16)
DOI 10.3390/cancers15164124, PubMed 37627152
Dominguez-Valentin M, Haupt S, Seppälä TT, Sampson JR, Sunde L, Bernstein I, Jenkins MA, Engel C, Aretz S, Nielsen M, Capella G, Balaguer F, Evans DG, Burn J, Holinski-Feder E, Bertario L, Bonanni B, Lindblom A, Levi Z, Macrae F, Winship I, Plazzer JP, Sijmons R, Laghi L, Della Valle A et al. (2023)
Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database
58, 101909
DOI 10.1016/j.eclinm.2023.101909, PubMed 37181409
Metcalfe K, Huzarski T, Gronwald J, Kotsopoulos J, Kim R, Moller P, Pal T, Aeilts A, Eisen A, Karlan B, Bordeleau L, Tung N, Olopade O, Zakalik D, Singer CF, Foulkes W, Couch F, Neuhausen SL, Eng C, Sun P, Lubinski J, Narod SA, Hereditary Breast Cancer Clinical Study Group (2023)
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis
130 (2), 269-274
DOI 10.1038/s41416-023-02503-8, PubMed 38030749
Møller P, Seppälä TT, Ahadova A, Crosbie EJ, Holinski-Feder E, Scott R, Haupt S, Möslein G, Winship I, Broeke SWB, Kohut KE, Ryan N, Bauerfeind P, Thomas LE, Evans DG, Aretz S, Sijmons RH, Half E, Heinimann K, Horisberger K, Monahan K, Engel C, Cavestro GM, Fruscio R, Abu-Freha N et al. (2023)
Dominantly inherited micro-satellite instable cancer - the four Lynch syndromes - an EHTG, PLSD position statement
21 (1), 19
DOI 10.1186/s13053-023-00263-3, PubMed 37821984
Ahadova A, Witt J, Haupt S, Gallon R, Hüneburg R, Nattermann J, Ten Broeke S, Bohaumilitzky L, Hernandez-Sanchez A, Santibanez-Koref M, Jackson MS, Ahtiainen M, Pylvänäinen K, Andini K, Grolmusz VK, Möslein G, Dominguez-Valentin M, Møller P, Fürst D, Sijmons R, Borthwick GM, Burn J, Mecklin JP, Heuveline V, von Knebel Doeberitz M et al. (2022)
Is HLA type a possible cancer risk modifier in Lynch syndrome?
152 (10), 2024-2031
DOI 10.1002/ijc.34312, PubMed 36214792
Cavestro GM, Mannucci A, Balaguer F, Hampel H, Kupfer SS, Repici A, Sartore-Bianchi A, Seppälä TT, Valentini V, Boland CR, Brand RE, Buffart TE, Burke CA, Caccialanza R, Cannizzaro R, Cascinu S, Cercek A, Crosbie EJ, Danese S, Dekker E, Daca-Alvarez M, Deni F, Dominguez-Valentin M, Eng C, Goel A et al. (2022)
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
21 (3), 581-603.e33
DOI 10.1016/j.cgh.2022.12.006, PubMed 36549470
Dominguez-Valentin M, Sampson JR, Seppälä TT, Møller P (2022)
Response to Chambuso et al
24 (5), 1151
DOI 10.1016/j.gim.2022.01.005, PubMed 35216900
Metcalfe KA, Gronwald J, Tung NM, McCuaig JM, Eisen A, Elser C, Foulkes WD, Neuhausen SL, Senter L, Moller P, Bordeleau L, Fruscio R, Velsher L, Zakalik D, Olopade OI, Eng C, Pal T, Cullinane CA, Couch FJ, Kotsopoulos J, Sun P, Lubinski J, Narod SA (2022)
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
129 (6), 901-907
DOI 10.1002/cncr.34615, PubMed 36571512
Møller P (2022)
The Prospective Lynch Syndrome Database: background, design, main results and complete MySQL code
20 (1), 37
DOI 10.1186/s13053-022-00243-z, PubMed 36411472
Møller P, Evans DG (2022)
Inherited Cancer Genetic Epidemiology to Improve Precision Medicine
11 (3)
DOI 10.3390/jcm11030879, PubMed 35160330
Møller P, Seppälä T, Dowty JG, Haupt S, Dominguez-Valentin M, Sunde L, Bernstein I, Engel C, Aretz S, Nielsen M, Capella G, Evans DG, Burn J, Holinski-Feder E, Bertario L, Bonanni B, Lindblom A, Levi Z, Macrae F, Winship I, Plazzer JP, Sijmons R, Laghi L, Valle AD, Heinimann K et al. (2022)
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium
20 (1), 36
DOI 10.1186/s13053-022-00241-1, PubMed 36182917
Thomassen M, Mesman RLS, Hansen TVO, Menendez M, Rossing M, Esteban-Sánchez A, Tudini E, Törngren T, Parsons MT, Pedersen IS, Teo SH, Kruse TA, Møller P, Borg Å, Jensen UB, Christensen LL, Singer CF, Muhr D, Santamarina M, Brandao R, Andresen BS, Feng BJ, Canson D, Richardson ME, Karam R et al. (2022)
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach
43 (12), 1921-1944
DOI 10.1002/humu.24449, PubMed 35979650
Xia YY, Gronwald J, Karlan B, Lubinski J, McCuaig JM, Brooks J, Moller P, Eisen A, Sun S, Senter L, Bordeleau L, Neuhausen SL, Singer CF, Tung N, Foulkes WD, Sun P, Narod SA, Kotsopoulos J, Hereditary Ovarian Cancer Clinical Study Group (2022)
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation
164 (3), 514-521
DOI 10.1016/j.ygyno.2022.01.014, PubMed 35063280
Zavaleta E, Solis N, Palacios MI, Zevallos-Escobar LE, Corales EV, Bazo-Alvarez JC, Dominguez-Barrera C, Campos A, Wernhoff P, Ekstrøm PO, Møller P, Visnovska T, Hovig E, Balazar-Palacios J, Alvarez-Valenzuela K, Nakken S, Dominguez-Valentin M (2022)
Genetic Characterization in High-Risk Individuals from a Low-Resource City of Peru
14 (22)
DOI 10.3390/cancers14225603, PubMed 36428697
Dominguez-Valentin M, Plazzer JP, Sampson JR, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Macrae F, Winship IM, Thomas H, Evans DG, Burn J, Greenblatt M, de Vos Tot Nederveen Cappel WH, Sijmons RH, Nielsen M, Bertario L, Bonanni B, Tibiletti MG, Cavestro GM, Lindblom A, Valle AD et al. (2021)
No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study
10 (13)
DOI 10.3390/jcm10132856, PubMed 34203177
Kim SJ, Lubinski J, Huzarski T, Møller P, Armel S, Karlan BY, Senter L, Eisen A, Foulkes WD, Singer CF, Tung N, Bordeleau L, Neuhausen SL, Olopade OI, Eng C, Weitzel JN, Fruscio R, Narod SA, Kotsopoulos J, Hereditary Ovarian Cancer Clinical Study Group (2021)
Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers
30 (11), 2038-2043
DOI 10.1158/1055-9965.EPI-21-0296, PubMed 34426412
Li H, Engel C, de la Hoya M, Peterlongo P, Yannoukakos D, Livraghi L, Radice P, Thomassen M, Hansen TVO, Gerdes AM, Nielsen HR, Caputo SM, Zambelli A, Borg A, Solano A, Thomas A, Parsons MT, Antoniou AC, Leslie G, Yang X, Chenevix-Trench G, Caldes T, Kwong A, Pedersen IS, Lautrup CK et al. (2021)
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants
24 (1), 119-129
DOI 10.1016/j.gim.2021.08.016, PubMed 34906479
Moller P, Sampson JR, Dominguez-Valentin M, Seppala TT (2021)
Towards evidence-based personalised precision medicine for Lynch syndrome
Lancet Oncol., 22 (9), E383
Møller P, Sampson J, Dominguez-Valentin M, Burn J, Sunde L, Möslein G, Mecklin JP, Seppälä T (2021)
Correction to: Letter to the Editor-Recent advances in Lynch syndrome
20 (2), 119
DOI 10.1007/s10689-021-00246-0, PubMed 33792829
Møller P, Sampson JR, Dominguez-Valentin M, Seppälä TT (2021)
Towards evidence-based personalised precision medicine for Lynch syndrome
22 (9), e383
DOI 10.1016/S1470-2045(21)00400-9, PubMed 34478667
Nakken S, Saveliev V, Hofmann O, Møller P, Myklebost O, Hovig E (2021)
Cancer Predisposition Sequencing Reporter (CPSR): A flexible variant report engine for high-throughput germline screening in cancer
149 (11), 1955-1960
DOI 10.1002/ijc.33749, PubMed 34310709
Seppälä TT, Dominguez-Valentin M, Crosbie EJ, Engel C, Aretz S, Macrae F, Winship I, Capella G, Thomas H, Hovig E, Nielsen M, Sijmons RH, Bertario L, Bonanni B, Tibiletti MG, Cavestro GM, Mints M, Gluck N, Katz L, Heinimann K, Vaccaro CA, Green K, Lalloo F, Hill J, Schmiegel W et al. (2021)
Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report
148, 124-133
DOI 10.1016/j.ejca.2021.02.022, PubMed 33743481
Stjepanovic N, Lubinski J, Moller P, Armel SR, Foulkes WD, Tung N, Neuhausen SL, Kotsopoulos J, Sun P, Sun S, Eisen A, Narod SA, Hereditary Breast Canc (2021)
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers
Breast Cancer Res. Treat., 187 (2), 515-523
DOI 10.1007/s10549-020-06072-9
Ahadova A, Seppälä TT, Engel C, Gallon R, Burn J, Holinski-Feder E, Steinke-Lange V, Möslein G, Nielsen M, Ten Broeke SW, Laghi L, Dominguez-Valentin M, Capella G, Macrae F, Scott R, Hüneburg R, Nattermann J, Hoffmeister M, Brenner H, Bläker H, von Knebel Doeberitz M, Sampson JR, Vasen H, Mecklin JP, Møller P et al. (2020)
The "unnatural" history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance
148 (4), 800-811
DOI 10.1002/ijc.33224, PubMed 32683684
Álvarez K, Orellana P, De la Fuente M, Canales T, Pinto E, Heine C, Solar B, Hurtado C, Møller P, Kronberg U, Zarate AJ, Dominguez-Valentin M, López-Köstner F (2020)
Spectrum and Frequency of Tumors, Cancer Risk and Survival in Chilean Families with Lynch Syndrome: Experience of the Implementation of a Registry
9 (6)
DOI 10.3390/jcm9061861, PubMed 32549215
Dominguez-Valentin M, Crosbie EJ, Engel C, Aretz S, Macrae F, Winship I, Capella G, Thomas H, Nakken S, Hovig E, Nielsen M, Sijmons RH, Bertario L, Bonanni B, Tibiletti MG, Cavestro GM, Mints M, Gluck N, Katz L, Heinimann K, Vaccaro CA, Green K, Lalloo F, Hill J, Schmiegel W et al. (2020)
Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report
23 (4), 705-712
DOI 10.1038/s41436-020-01029-1, PubMed 33257847
Dominguez-Valentin M, Sampson JR, Møller P, Seppälä TT, PLSD Collaborators (2020)
Analysis in the Prospective Lynch Syndrome Database identifies sarcoma as part of the Lynch syndrome tumor spectrum
148 (2), 512-513
DOI 10.1002/ijc.33214, PubMed 32783184
Dominguez-Valentin M, Sampson JR, Seppälä TT, Ten Broeke SW, Plazzer JP, Nakken S, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Thomas H, Evans DG, Burn J, Greenblatt M, Hovig E, de Vos Tot Nederveen Cappel WH, Sijmons RH, Bertario L, Tibiletti MG, Cavestro GM, Lindblom A, Della Valle A et al. (2020)
Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
22 (9), 1569
DOI 10.1038/s41436-020-0892-4, PubMed 32690931
Dominguez-Valentin M, Seppälä TT, Engel C, Aretz S, Macrae F, Winship I, Capella G, Thomas H, Hovig E, Nielsen M, Sijmons RH, Bertario L, Bonanni B, Tibiletti MG, Cavestro GM, Mints M, Gluck N, Katz L, Heinimann K, Vaccaro CA, Green K, Lalloo F, Hill J, Schmiegel W, Vangala D et al. (2020)
Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database
9 (7)
DOI 10.3390/jcm9072290, PubMed 32708519
Kotsopoulos J, Karlan B, Gronwald J, Hall E, Moller P, Tung N, Zakalik D, Foulkes WD, Rosen B, Neuhausen SL, Sun P, Lubinksi J, Narod SA (2020)
Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among BRCA1 and BRCA2 mutation carriers
30 (6), 825-830
DOI 10.1136/ijgc-2019-001141, PubMed 32354794
Møller P (2020)
The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care
18, 6
DOI 10.1186/s13053-020-0138-0, PubMed 32190163
Møller P, Dominguez-Valentin M, Rødland EA, Hovig E (2020)
Correction: Møller, P.; et al. Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. Cancers 2019, 11, 132
12 (2)
DOI 10.3390/cancers12020410, PubMed 32050665
Møller P, Sampson J, Dominguez-Valentin M, Burn J, Sunde L, Möslein G, Mecklin JP, Seppälä T (2020)
Letter to the Editor-Recent advances in Lynch syndrome
20 (2), 117-118
DOI 10.1007/s10689-020-00200-6, PubMed 32770425
Piñero TA, Soukarieh O, Rolain M, Alvarez K, López-Köstner F, Torrezan GT, Carraro DM, De Oliveira Nascimento IL, Bomfim TF, Machado-Lopes TMB, Freitas JC, Toralles MB, Sandes KA, Rossi BM, Junior SA, Meira J, Dominguez-Valentin M, Møller P, Vaccaro CA, Martins A, Pavicic WH (2020)
MLH1 intronic variants mapping to + 5 position of splice donor sites lead to deleterious effects on RNA splicing
19 (4), 323-336
DOI 10.1007/s10689-020-00182-5, PubMed 32363481
Seppälä TT, Dominguez-Valentin M, Sampson JR, Møller P (2020)
Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)
20 (1), 35-39
DOI 10.1007/s10689-020-00193-2, PubMed 32507935
Crosbie EJ, Ryan NAJ, Arends MJ, Bosse T, Burn J, Cornes JM, Crawford R, Eccles D, Frayling IM, Ghaem-Maghami S, Hampel H, Kauff ND, Kitchener HC, Kitson SJ, Manchanda R, McMahon RFT, Monahan KJ, Menon U, Møller P, Möslein G, Rosenthal A, Sasieni P, Seif MW, Singh N, Skarrott P et al. (2019)
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome
21 (10), 2390-2400
DOI 10.1038/s41436-019-0489-y, PubMed 30918358
Della Valle A, Rossi BM, Palmero EI, Antelo M, Vaccaro CA, López-Kostner F, Alvarez K, Cruz-Correa M, Bruno LI, Forones NM, Mindiola JAR, Buleje J, Spirandelli F, Bohorquez M, Cock-Rada AM, Sullcahuaman Y, Nascimento I, Abe-Sandes K, Lino-Silva LS, Petracchi F, Mampel A, Rodriguez Y, Rossi NT, Yañez CB, Rubio C et al. (2019)
A snapshot of current genetic testing practice in Lynch syndrome: The results of a representative survey of 33 Latin American existing centres/registries
119, 112-121
DOI 10.1016/j.ejca.2019.07.017, PubMed 31442815
Dominguez-Valentin M, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Holth A, Capella G, Davidson B, Evans DG, Martins A, Møller P, Hovig E (2019)
Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing
9 (1), 18555
DOI 10.1038/s41598-019-54517-z, PubMed 31811167
Dominguez-Valentin M, Sampson JR, Seppälä TT, Ten Broeke SW, Plazzer JP, Nakken S, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Thomas H, Evans DG, Burn J, Greenblatt M, Hovig E, de Vos Tot Nederveen Cappel WH, Sijmons RH, Bertario L, Tibiletti MG, Cavestro GM, Lindblom A, Della Valle A et al. (2019)
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
22 (1), 15-25
DOI 10.1038/s41436-019-0596-9, PubMed 31337882
Dominguez-Valentin M, Seppälä TT, Sampson JR, Macrae F, Winship I, Evans DG, Scott RJ, Burn J, Möslein G, Bernstein I, Pylvänäinen K, Renkonen-Sinisalo L, Lepistö A, Lindblom A, Plazzer JP, Tjandra D, Thomas H, Green K, Lalloo F, Crosbie EJ, Hill J, Capella G, Pineda M, Navarro M, Vidal JB et al. (2019)
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report
17, 28
DOI 10.1186/s13053-019-0127-3, PubMed 31636762
Kotsopoulos J, Lubinski J, Lynch HT, Tung N, Armel S, Senter L, Singer CF, Fruscio R, Couch F, Weitzel JN, Karlan B, Foulkes WD, Moller P, Eisen A, Ainsworth P, Neuhausen SL, Olopade O, Sun P, Gronwald J, Narod SA, Hereditary Breast Cancer Clinical Study Group (2019)
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers
175 (2), 443-449
DOI 10.1007/s10549-019-05162-7, PubMed 30756284
Metcalfe K, Eisen A, Senter L, Armel S, Bordeleau L, Meschino WS, Pal T, Lynch HT, Tung NM, Kwong A, Ainsworth P, Karlan B, Moller P, Eng C, Weitzel JN, Sun P, Lubinski J, Narod SA, Hereditary Breast Cancer Clinical Study Group (2019)
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation
121 (1), 15-21
DOI 10.1038/s41416-019-0446-1, PubMed 30971774
Møller P, Dominguez-Valentin M, Rødland EA, Hovig E (2019)
Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift
11 (2)
DOI 10.3390/cancers11020132, PubMed 30678073
Sampson JR, Dominguez-Valentin M, Seppälä TT, Møller P (2019)
Response to Tolva et al
22 (4), 813-814
DOI 10.1038/s41436-019-0717-5, PubMed 31801985
Seppälä TT, Ahadova A, Dominguez-Valentin M, Macrae F, Evans DG, Therkildsen C, Sampson J, Scott R, Burn J, Möslein G, Bernstein I, Holinski-Feder E, Pylvänäinen K, Renkonen-Sinisalo L, Lepistö A, Lautrup CK, Lindblom A, Plazzer JP, Winship I, Tjandra D, Katz LH, Aretz S, Hüneburg R, Holzapfel S, Heinimann K et al. (2019)
Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report
17, 8
DOI 10.1186/s13053-019-0106-8, PubMed 30858900
Ten Broeke SW, Rodríguez-Girondo M, Suerink M, Aretz S, Bernstein I, Capellá G, Engel C, Gomez-Garcia EB, van Hest LP, von Knebel Doeberitz M, Lagerstedt-Robinson K, Letteboer TGW, Moller P, van Os TA, Pineda M, Rahner N, Olderode-Berends MJW, von Salomé J, Schackert HK, Spruijt L, Steinke-Lange V, Wagner A, Tops CMJ, Nielsen M (2019)
The Apparent Genetic Anticipation in PMS2-Associated Lynch Syndrome Families Is Explained by Birth-cohort Effect
28 (6), 1010-1014
DOI 10.1158/1055-9965.EPI-18-0576, PubMed 30824524
Dominguez-Valentin M, Evans DGR, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Martins A, Møller P, Hovig E (2018)
Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds
16, 4
DOI 10.1186/s13053-018-0086-0, PubMed 29371908
Dominguez-Valentin M, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Martins A, Møller P, Hovig E (2018)
Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families
17 (1), 141-153
DOI 10.1007/s10689-017-0011-0, PubMed 28608266
Dominguez-Valentin M, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Martins A, Møller P, Hovig E (2018)
Identification of genetic variants for clinical management of familial colorectal tumors
19 (1), 26
DOI 10.1186/s12881-018-0533-9, PubMed 29458332
Ebenesersdóttir SS, Sandoval-Velasco M, Gunnarsdóttir ED, Jagadeesan A, Guðmundsdóttir VB, Thordardóttir EL, Einarsdóttir MS, Moore KHS, Sigurðsson Á, Magnúsdóttir DN, Jónsson H, Snorradóttir S, Hovig E, Møller P, Kockum I, Olsson T, Alfredsson L, Hansen TF, Werge T, Cavalleri GL, Gilbert E, Lalueza-Fox C, Walser JW, Kristjánsdóttir S, Gopalakrishnan S et al. (2018)
Ancient genomes from Iceland reveal the making of a human population
360 (6392), 1028-1032
DOI 10.1126/science.aar2625, PubMed 29853688
Kim SJ, Huzarski T, Gronwald J, Singer CF, Møller P, Lynch HT, Armel S, Karlan BY, Foulkes WD, Neuhausen SL, Senter L, Eisen A, Eng C, Panchal S, Pal T, Olopade O, Zakalik D, Lubinski J, Narod SA, Kotsopoulos J, (2018)
Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers
47 (3), 987-997
DOI 10.1093/ije/dyy039, PubMed 29547931
Kotsopoulos J, Gronwald J, Karlan B, Rosen B, Huzarski T, Moller P, Lynch HT, Singer CF, Senter L, Neuhausen SL, Tung N, Eisen A, Foulkes WD, Ainsworth P, Sun P, Lubinski J, Narod SA, Hereditary Ovarian Cancer Clinical Study Group (2018)
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation
150 (1), 85-91
DOI 10.1016/j.ygyno.2018.05.011, PubMed 29793803
Kotsopoulos J, Gronwald J, Karlan BY, Huzarski T, Tung N, Moller P, Armel S, Lynch HT, Senter L, Eisen A, Singer CF, Foulkes WD, Jacobson MR, Sun P, Lubinski J, Narod SA, Hereditary Breast Cancer Clinical Study Group (2018)
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers
4 (8), 1059-1065
DOI 10.1001/jamaoncol.2018.0211, PubMed 29710224
Møller P, Hovig E (2018)
Our genes, our selves: hereditary breast cancer and biological citizenship in Norway
21 (2), 239-242
DOI 10.1007/s11019-017-9803-0, PubMed 28939999
Møller P, Hovig E (2018)
Retraction Note to: The BRCA2 variant c.68-7 T > A is associated with breast cancer
16, 10
DOI 10.1186/s13053-018-0093-1, PubMed 29745381
Ten Broeke SW, van der Klift HM, Tops CMJ, Aretz S, Bernstein I, Buchanan DD, de la Chapelle A, Capella G, Clendenning M, Engel C, Gallinger S, Gomez Garcia E, Figueiredo JC, Haile R, Hampel HL, Hopper JL, Hoogerbrugge N, von Knebel Doeberitz M, Le Marchand L, Letteboer TGW, Jenkins MA, Lindblom A, Lindor NM, Mensenkamp AR, Møller P et al. (2018)
Cancer Risks for PMS2-Associated Lynch Syndrome
36 (29), 2961-2968
DOI 10.1200/JCO.2018.78.4777, PubMed 30161022
Vaccaro CA, López-Kostner F, Adriana DV, Palmero EI, Rossi BM, Antelo M, Solano A, Carraro DM, Forones NM, Bohorquez M, Lino-Silva LS, Buleje J, Spirandelli F, Abe-Sandes K, Nascimento I, Sullcahuaman Y, Sarroca C, Gonzalez ML, Herrando AI, Alvarez K, Neffa F, Galvão HC, Esperon P, Golubicki M, Cisterna D et al. (2018)
From colorectal cancer pattern to the characterization of individuals at risk: Picture for genetic research in Latin America
145 (2), 318-326
DOI 10.1002/ijc.31920, PubMed 30303536
Møller P, Hovig E (2017)
The BRCA2 variant c.68-7 T>A is associated with breast cancer
15, 20 (Retracted)
DOI 10.1186/s13053-017-0080-y, PubMed 29158857
Møller P, Seppälä TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D, Lindblom A, Macrae F, Blanco I, Sijmons RH, Jeffries J, Vasen HFA, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen JT, Jenkins MA, Green K, Lalloo F, Sunde L, Mints M et al. (2017)
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
67 (7), 1306-1316
DOI 10.1136/gutjnl-2017-314057, PubMed 28754778
Rossi BM, Palmero EI, López-Kostner F, Sarroca C, Vaccaro CA, Spirandelli F, Ashton-Prolla P, Rodriguez Y, de Campos Reis Galvão H, Reis RM, Escremim de Paula A, Capochin Romagnolo LG, Alvarez K, Della Valle A, Neffa F, Kalfayan PG, Spirandelli E, Chialina S, Gutiérrez Angulo M, Castro-Mujica MDC, Sanchez de Monte J, Quispe R, da Silva SD, Rossi NT, Barletta-Carrillo C et al. (2017)
A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America
17 (1), 623
DOI 10.1186/s12885-017-3599-4, PubMed 28874130
Seppälä T, Pylvänäinen K, Evans DG, Järvinen H, Renkonen-Sinisalo L, Bernstein I, Holinski-Feder E, Sala P, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Genuardi M, Green K et al. (2017)
Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report
15, 18
DOI 10.1186/s13053-017-0078-5, PubMed 29046738
Kotsopoulos J, Huzarski T, Gronwald J, Moller P, Lynch HT, Neuhausen SL, Senter L, Demsky R, Foulkes WD, Eng C, Karlan B, Tung N, Singer CF, Sun P, Lubinski J, Narod SA (2016)
Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study
155 (2), 365-73
DOI 10.1007/s10549-016-3685-3, PubMed 26780555
Kotsopoulos J, Huzarski T, Gronwald J, Singer CF, Moller P, Lynch HT, Armel S, Karlan B, Foulkes WD, Neuhausen SL, Senter L, Tung N, Weitzel JN, Eisen A, Metcalfe K, Eng C, Pal T, Evans G, Sun P, Lubinski J, Narod SA, Hereditary Breast Cancer Clinical Study Group (2016)
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
109 (1)
DOI 10.1093/jnci/djw177, PubMed 27601060
Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Green K, Lalloo F, Sunde L, Mints M et al. (2016)
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
66 (9), 1657-1664
DOI 10.1136/gutjnl-2016-311403, PubMed 27261338
Gronwald J, Glass K, Rosen B, Karlan B, Tung N, Neuhausen SL, Moller P, Ainsworth P, Sun P, Narod SA, Lubinski J, Kotsopoulos J, Hereditary Breast Cancer Clinical Study Group (2015)
Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation
105 (3), 781-785
DOI 10.1016/j.fertnstert.2015.11.034, PubMed 26698676
Heramb C, Ekstrøm PO, Tharmaratnam K, Hovig E, Møller P, Mæhle L (2015)
Ten modifiers of BRCA1 penetrance validated in a Norwegian series
13 (1), 14
DOI 10.1186/s13053-015-0035-0, PubMed 26052370
Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Green K, Lalloo F, Sunde L, Mints M, Bertario L et al. (2015)
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
66 (3), 464-472
DOI 10.1136/gutjnl-2015-309675, PubMed 26657901
Møller P, Tharmaratnam K, Howell A, Stavrinos P, Sampson S, Wallace A, Maxwell AJ, Hagen AI, Evans DG (2015)
Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography
152 (1), 87-94
DOI 10.1007/s10549-015-3448-6, PubMed 26037256
Segev Y, Rosen B, Lubinski J, Gronwald J, Lynch HT, Moller P, Kim-Sing C, Ghadirian P, Karlan B, Eng C, Gilchrist D, Neuhausen SL, Eisen A, Friedman E, Euhus D, Ping S, Narod SA, Hereditary Breast Canc Study Grp (2015)
Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study
Fam. Cancer, 14 (3), 383-391
DOI 10.1007/s10689-015-9798-8
Suerink M, van der Klift HM, Ten Broeke SW, Dekkers OM, Bernstein I, Capellá Munar G, Gomez Garcia E, Hoogerbrugge N, Letteboer TG, Menko FH, Lindblom A, Mensenkamp A, Moller P, van Os TA, Rahner N, Redeker BJ, Olderode-Berends MJ, Spruijt L, Vos YJ, Wagner A, Morreau H, Hes FJ, Vasen HF, Tops CM, Wijnen JT et al. (2015)
The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers
18 (4), 405-9
DOI 10.1038/gim.2015.83, PubMed 26110232
Tricarico R, Cortellino S, Riccio A, Jagmohan-Changur S, Van der Klift H, Wijnen J, Turner D, Ventura A, Rovella V, Percesepe A, Lucci-Cordisco E, Radice P, Bertario L, Pedroni M, de Leon MP, Mancuso P, Devarajan K, Cai KQ, Klein-Szanto AJP, Neri G, Moller P, Viel A, Genuardi M, Fodde R, Bellacosa A (2015)
Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis
Oncotarget, 6 (40), 42892-42904
DOI 10.18632/oncotarget.5740
Finch AP, Lubinski J, Møller P, Singer CF, Karlan B, Senter L, Rosen B, Maehle L, Ghadirian P, Cybulski C, Huzarski T, Eisen A, Foulkes WD, Kim-Sing C, Ainsworth P, Tung N, Lynch HT, Neuhausen S, Metcalfe KA, Thompson I, Murphy J, Sun P, Narod SA (2014)
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation
32 (15), 1547-53
DOI 10.1200/JCO.2013.53.2820, PubMed 24567435
Giannakeas V, Lubinski J, Gronwald J, Moller P, Armel S, Lynch HT, Foulkes WD, Kim-Sing C, Singer C, Neuhausen SL, Friedman E, Tung N, Senter L, Sun P, Narod SA (2014)
Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study
Breast Cancer Res. Treat., 147 (1), 113-118
DOI 10.1007/s10549-014-3063-y
Grindedal EM, Aarset H, Bjørnevoll I, Røyset E, Mæhle L, Stormorken A, Heramb C, Medvik H, Møller P, Sjursen W (2014)
The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry
12 (1), 12
DOI 10.1186/1897-4287-12-12, PubMed 24790682
Gronwald J, Robidoux A, Kim-Sing C, Tung N, Lynch HT, Foulkes WD, Manoukian S, Ainsworth P, Neuhausen SL, Demsky R, Eisen A, Singer CF, Saal H, Senter L, Eng C, Weitzel J, Moller P, Gilchrist DM, Olopade O, Ginsburg O, Sun P, Huzarski T, Lubinski J, Narod SA, Hereditary Breast Canc Clinical (2014)
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
Breast Cancer Res. Treat., 146 (2), 421-427
DOI 10.1007/s10549-014-3026-3
Kotsopoulos J, Lubinski J, Gronwald J, Cybulski C, Demsky R, Neuhausen SL, Kim-Sing C, Tung N, Friedman S, Senter L, Weitzel J, Karlan B, Moller P, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group (2014)
Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
137 (5), 1136-46
DOI 10.1002/ijc.29386, PubMed 25482078
Kotsopoulos J, Lubinski J, Moller P, Lynch HT, Singer CF, Eng C, Neuhausen SL, Karlan B, Kim-Sing C, Huzarski T, Gronwald J, McCuaig J, Senter L, Tung N, Ghadirian P, Eisen A, Gilchrist D, Blum JL, Zakalik D, Pal T, Sun P, Narod SA, Hereditary Breast Canc Clinical St (2014)
Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers
Breast Cancer Res. Treat., 143 (3), 579-586
DOI 10.1007/s10549-013-2823-4
Møller P, Stormorken A, Holmen MM, Hagen AI, Vabø A, Mæhle L (2014)
The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation
144 (3), 607-14
DOI 10.1007/s10549-014-2902-1, PubMed 24619173
Nieuwenhuis MH, Kets CM, Murphy-Ryan M, Yntema HG, Evans DG, Colas C, Moller P, Hes FJ, Hodgson SV, Olderode-Berends MJW, Aretz S, Heinimann K, Garcia EBG, Douglas F, Spigelman A, Timshel S, Lindor NM, Vasen HFA (2014)
Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome
Fam. Cancer, 13 (1), 57-63
DOI 10.1007/s10689-013-9674-3
ten Broeke SW, Brohet RM, Tops CM, van der Klift HM, Velthuizen ME, Bernstein I, Capellá Munar G, Gomez Garcia E, Hoogerbrugge N, Letteboer TG, Menko FH, Lindblom A, Mensenkamp AR, Moller P, van Os TA, Rahner N, Redeker BJ, Sijmons RH, Spruijt L, Suerink M, Vos YJ, Wagner A, Hes FJ, Vasen HF, Nielsen M et al. (2014)
Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk
33 (4), 319-25
DOI 10.1200/JCO.2014.57.8088, PubMed 25512458
Tharmaratnam K, Hagen AI, Moller P (2014)
MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis
Breast Cancer Res. Treat., 148 (3), 687-688
DOI 10.1007/s10549-014-3178-1
Hagen AI, Mæhle L, Vedå N, Vetti HH, Stormorken A, Ludvigsen T, Guntvedt B, Isern AE, Schlichting E, Kleppe G, Bofin A, Gullestad HP, Møller P (2013)
Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriers
23 (1), 38-43
DOI 10.1016/j.breast.2013.10.002, PubMed 24210736
Møller P, Stormorken A, Jonsrud C, Holmen MM, Hagen AI, Clark N, Vabø A, Sun P, Narod SA, Mæhle L (2013)
Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program
139 (1), 155-61
DOI 10.1007/s10549-013-2540-z, PubMed 23615785
Segev Y, Iqbal J, Lubinski J, Gronwald J, Lynch HT, Moller P, Ghadirian P, Rosen B, Tung N, Kim-Sing C, Foulkes WD, Neuhausen SL, Senter L, Singer CF, Karlan B, Ping S, Narod SA, Hereditary Breast Canc Study Grp (2013)
The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: An international prospective cohort study
Gynecol. Oncol., 130 (1), 127-131
DOI 10.1016/j.ygyno.2013.03.027
Talseth-Palmer BA, Wijnen JT, Brenne IS, Jagmohan-Changur S, Barker D, Ashton KA, Tops CM, Evans TJ, McPhillips M, Groombridge C, Suchy J, Kurzawski G, Spigelman A, Moller P, Morreau HM, Van Wezel T, Lubinski J, Vasen HFA, Scott RJ, Dutch Canc Genetics Grp (2013)
Combined analysis of three lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers
Int. J. Cancer, 132 (7), 1556-1564
DOI 10.1002/ijc.27843
Thompson BA, Spurdle AB, Plazzer JP, Greenblatt MS, Akagi K, Al-Mulla F, Bapat B, Bernstein I, Capellá G, den Dunnen JT, du Sart D, Fabre A, Farrell MP, Farrington SM, Frayling IM, Frebourg T, Goldgar DE, Heinen CD, Holinski-Feder E, Kohonen-Corish M, Robinson KL, Leung SY, Martins A, Moller P, Morak M et al. (2013)
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database
46 (2), 107-115
DOI 10.1038/ng.2854, PubMed 24362816
Valentini A, Lubinski J, Byrski T, Ghadirian P, Moller P, Lynch H, Ainsworth P, Neuhausen SL, Weitzel J, Singer CF, Olopade OI, Saal H, Lyonnet DS, Foulkes WD, Kim-Sing C, Manoukian S, Zakalik D, Armel S, Senter L, Eng C, Grunfeld E, Chiarelli AM, Poll A, Sun P, Narod SA et al. (2013)
The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation
Breast Cancer Res. Treat., 142 (1), 177-185
DOI 10.1007/s10549-013-2729-1
Vasen HFA, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S, Bernstein I, Bertario L, Burn J, Capella G, Colas C, Engel C, Frayling IM, Genuardi M, Heinimann K, Hes FJ, Hodgson SV, Karagiannis JA, Lalloo F, Lindblom A, Mecklin JP, Moller P, Myrhoj T, Nagengast FM, Parc Y et al. (2013)
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
Gut, 62 (6), 812-823
DOI 10.1136/gutjnl-2012-304356
Xu JF, Lange EM, Lu LY, Zheng SQL, Wang Z, Thibodeau SN, Cannon-Albright LA, Teerlink CC, Camp NJ, Johnson AM, Zuhlke KA, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Maier C, Luedeke M, Vogel W, Schleutker J, Wahlfors T, Tammela T, Schaid D, McDonnell SK, DeRycke MS et al. (2013)
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)
Hum. Genet., 132 (1), 5-14
DOI 10.1007/s00439-012-1229-4
Bailey-Wilson JE, Childs EJ, Cropp CD, Schaid DJ, Xu J, Camp NJ, Cannon-Albright LA, Farnham JM, George A, Powell I, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Mæhle L, Møller P, Eeles R, Easton D, Guy M, Edwards S, Badzioch MD, Whittemore AS, Oakley-Girvan I et al. (2012)
Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families
13, 46
DOI 10.1186/1471-2350-13-46, PubMed 22712434
Nieuwenhuis MH, Kets CM, Murphy-Ryan M, Colas C, Möller P, Hes FJ, Hodgson SV, Olderode-Berends MJ, Aretz S, Heinimann K, Gomez Garcia EB, Douglas F, Spigelman A, Timshel S, Lindor NM, Vasen HF (2012)
Is colorectal surveillance indicated in patients with PTEN mutations?
14 (9), e562-6
DOI 10.1111/j.1463-1318.2012.03121.x, PubMed 22672595
Kohonen-Corish MRJ, Macrae F, Genuardi M, Aretz S, Bapat B, Bernstein IT, Burn J, Cotton RGH, den Dunnen JT, Frebourg T, Greenblatt MS, Hofstra R, Holinski-Feder E, Lappalainen I, Lindblom A, Maglott D, Moller P, Morreau H, Moslein G, Sijmons R, Spurdle AB, Tavtigian S, Tops CMJ, Weber TK, de Wind N et al. (2011)
Deciphering the Colon Cancer Genes-Report of the InSiGHT-Human Variome Project Workshop, UNESCO, Paris 2010
Hum. Mutat., 32 (4), 491-494
DOI 10.1002/humu.21450
Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TL, Schleutker J, Hoegel J, Herkommer K, Maier C, Vogel W, Wiklund F, Emanuelsson M, Grönberg H, Wiley KE, Isaacs SD, Walsh PC, Helfand BT, Kan D, Catalona WJ, Stanford JL et al. (2011)
Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG
72 (4), 410-26
DOI 10.1002/pros.21443, PubMed 21748754
Moller P, Clark N (2011)
CGEN-A Clinical GENetics Software Application
Hum. Mutat., 32 (5), 537-542
DOI 10.1002/humu.21452
Møller P, Clark N, Mæhle L (2011)
A SImplified method for Segregation Analysis (SISA) to determine penetrance and expression of a genetic variant in a family
32 (5), 568-71
DOI 10.1002/humu.21441, PubMed 21309035
Arason A, Gunnarsson H, Johannesdottir G, Jonasson K, Bendahl PO, Gillanders EM, Agnarsson BA, Jonsson G, Pylkas K, Mustonen A, Heikkinen T, Aittomaki K, Blomqvist C, Melin B, Johannsson OTH, Moller P, Winqvist R, Nevanlinna H, Borg A, Barkardottir RB (2010)
Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families
Breast Cancer Res., 12 (4), R50
DOI 10.1186/bcr2608
Bodd TL, Van Ghelue M, Eiklid K, Ruud E, Møller P, Mæhle L (2010)
Fanconi anaemia, BRCA2 and familial considerations - follow up on a previous case report
99 (11), 1741-3
DOI 10.1111/j.1651-2227.2010.01929.x, PubMed 20608899
Christensen GB, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Seven G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu JF, Stanford JL, Johanneson B, Deutsch K, McIntosh L et al. (2010)
Genome-Wide Linkage Analysis of 1,233 Prostate Cancer Pedigrees From the International Consortium for Prostate Cancer Genetics Using Novel sum LINK and sum LOD Analyses
Prostate, 70 (7), 735-744
DOI 10.1002/pros.21106
Dennis J, Ghadirian P, Little J, Lubinski J, Gronwald J, Kim-Sing C, Foulkes W, Moller P, Lynch HT, Neuhausen SL, Domchek S, Armel S, Isaacs C, Tung N, Sweet K, Ainsworth P, Sun P, Krewski D, Narod S, Hereditary Breast Canc Clinical St (2010)
Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers
Breast, 19 (6), 479-483
DOI 10.1016/j.breast.2010.05.009
Møller P, Mæhle L, Engebretsen LF, Ludvigsen T, Jonsrud C, Apold J, Vabø A, Clark N (2010)
High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series
8 (1), 2
DOI 10.1186/1897-4287-8-2, PubMed 20180971
Sjursen W, Haukanes BI, Grindedal EM, Aarset H, Stormorken A, Engebretsen LF, Jonsrud C, Bjørnevoll I, Andresen PA, Ariansen S, Lavik LA, Gilde B, Bowitz-Lothe IM, Maehle L, Møller P (2010)
Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers
47 (9), 579-85
DOI 10.1136/jmg.2010.077677, PubMed 20587412
Ginsburg O, Ghadirian P, Lubinski J, Cybulski C, Lynch H, Neuhausen S, Kim-Sing C, Robson M, Domchek S, Isaacs C, Klijn J, Armel S, Foulkes WD, Tung N, Moller P, Sun P, Narod SA, Hereditary Breast Canc Clinical St (2009)
Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update
Breast Cancer Res. Treat., 114 (1), 127-135
DOI 10.1007/s10549-008-9977-5
Grindedal EM, Møller P, Eeles R, Stormorken AT, Bowitz-Lothe IM, Landrø SM, Clark N, Kvåle R, Shanley S, Maehle L (2009)
Germ-line mutations in mismatch repair genes associated with prostate cancer
18 (9), 2460-7
DOI 10.1158/1055-9965.EPI-09-0058, PubMed 19723918
Grindedal EM, Renkonen-Sinisalo L, Vasen H, Evans G, Sala P, Blanco I, Gronwald J, Apold J, Eccles DM, Sánchez AA, Sampson J, Järvinen HJ, Bertario L, Crawford GC, Stormorken AT, Maehle L, Moller P (2009)
Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds
47 (2), 99-102
DOI 10.1136/jmg.2009.068130, PubMed 19635727
Hagen AI, Tretli S, Maehle L, Apold J, Veda N, Moller P (2009)
Survival in Norwegian BRCA1 mutation carriers with breast cancer
Hered. Cancer Clin. Pract., 7, 7
DOI 10.1186/1897-4287-7-7
Eisen A, Lubinski J, Gronwald J, Moller P, Lynch HT, Klijn J, Kim-Sing C, Neuhausen SL, Gilbert L, Ghadirian P, Manoukian S, Rennert G, Friedman E, Isaacs C, Rosen E, Rosen B, Daly M, Sun P, Narod SA, Hereditary Breast Canc Clinical St (2008)
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers
J. Natl. Cancer Inst., 100 (19), 1361-1367
DOI 10.1093/jnci/djn313
Grindedal EM, Blanco I, Stormorken A, Maehle L, Clark N, González S, Capella G, Vasen H, Burn J, Møller P (2008)
High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers
8 (2), 145-51
DOI 10.1007/s10689-008-9219-3, PubMed 18841495
Kotsopoulos J, Librach C, Lubinski J, Gronwald J, Kim-Sing C, Ghadirian P, Lynch H, Moller P, Foulkes W, Randall S, Manoukian S, Pasini B, Tung N, Ainsworth P, Cummings S, Sun P, Narod S, Hereditary Breast Canc Clinical St (2008)
Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study
Cancer Causes Control, 19 (10), 1111-1119
DOI 10.1007/s10552-008-9175-0
Maehle L, Apold J, Paulsen T, Hagen B, Løvslett K, Fiane B, Van Ghelue M, Clark N, Møller P (2008)
High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers
14 (22), 7569-73
DOI 10.1158/1078-0432.CCR-08-0112, PubMed 19010876
Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, Tung N, Manoukian S, Couch F, Sun P, Narod SA, Hereditary Breast Canc Clin Study (2008)
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
Int. J. Cancer, 122 (9), 2017-2022
DOI 10.1002/ijc.23340
Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Moller P, Weitzel J, Sun P, Narod SA (2008)
Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: The hereditary breast cancer clinical study group
J. Clin. Oncol., 26 (7), 1093-1097
DOI 10.1200/JCO.2007.12.6078
Norum J, Hagen AI, Maehle L, Apold J, Burn J, Moller P (2008)
Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: A cost-effectiveness analysis
Eur. J. Cancer, 44 (7), 963-971
DOI 10.1016/j.ejca.2008.02.025
Reichelt JG, Møller P, Heimdal K, Dahl AA (2008)
Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer
7 (3), 245-54
DOI 10.1007/s10689-008-9182-z, PubMed 18219587
Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B et al. (2007)
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics
16 (11), 1271-8
DOI 10.1093/hmg/ddm075, PubMed 17478474
Elsakov P, Foretova L, Goetz P, de Groot JWB, van der Graaf WTA, Guler G, Huebner K, Haites NE, Hamann U, Ho J, Imyanitov EN, Irmejs A, Purkalne G, Bitina M, Gardovskis A, Gardovskis J, Kirova YM, Fourquet A, Pierga JY, Stoppa-Lyonnet D, Larizza L, Lips CJM, Loman N, Borg A, Moller P et al. (2007)
Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers
Hered. Cancer Clin. Pract., 5 (3), 119-143
Hagen AI, Bofin AM, Ytterhus B, Maehle LO, Kjellevold KH, Myhre HO, Møller P, Lønning PE (2007)
Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations
46 (2), 199-203
DOI 10.1080/02841860600949552, PubMed 17453369
Hagen AI, Kvistad KA, Maehle L, Holmen MM, Aase H, Styr B, Vabø A, Apold J, Skaane P, Møller P (2007)
Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series
16 (4), 367-74
DOI 10.1016/j.breast.2007.01.006, PubMed 17317184
Kotsopoulos J, Lubinski J, Lynch HT, Klijn J, Ghadirian P, Neuhausen SL, Kim-Sing C, Foulkes WD, Moller P, Isaacs C, Domchek S, Randall S, Offit K, Tung N, Ainsworth P, Gershoni-Baruch R, Eisen A, Daly M, Karlan B, Saal HM, Couch F, Pasini B, Wagner T, Friedman E, Rennert G et al. (2007)
Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
105 (2), 221-8
DOI 10.1007/s10549-006-9441-3, PubMed 17245541
McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL, Offit K, Kauff N, Domchek S, Tung N, Friedman E, Foulkes W, Sun P, Narod SA, Hereditary Ovarian Cancer Clinical Study Group (2007)
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study
8 (1), 26-34
DOI 10.1016/S1470-2045(06)70983-4, PubMed 17196508
Moller P, Evans DG, Reis MM, Gregory H, Anderson E, Maehle L, Lalloo F, Howell A, Apold J, Clark N, Lucassen A, Steel CM (2007)
Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status
121 (5), 1017-20
DOI 10.1002/ijc.22789, PubMed 17471561
Møller P, Hagen AI, Apold J, Maehle L, Clark N, Fiane B, Løvslett K, Hovig E, Vabø A (2007)
Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers
43 (11), 1713-7
DOI 10.1016/j.ejca.2007.04.023, PubMed 17574839
Møller P, Maehle L, Clark N, Apold J (2007)
No sib pair concordance for breast or ovarian cancer in BRCA1 mutation carriers
5 (2), 67-71
DOI 10.1186/1897-4287-5-2-67, PubMed 19725986
Stormorken AT, Clark N, Grindedal E, Maehle L, Møller P (2007)
Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancer
42 (5), 611-7
DOI 10.1080/00365520601010230, PubMed 17454882
Beiner ME, Finch A, Rosen B, Lubinski J, Moller P, Ghadirian P, Lynch HT, Friedman E, Sun P, Narod SA, Hereditary Ovarian Cancer Clinical Study Group (2006)
The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study
104 (1), 7-10
DOI 10.1016/j.ygyno.2006.08.004, PubMed 16962648
Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B, Weitzel J, Sun P et al. (2006)
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation
296 (2), 185-92
DOI 10.1001/jama.296.2.185, PubMed 16835424
Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P, Neuhausen SL, Isaacs C, Weber B, Foulkes WD, Moller P, Rosen B, Kim-Sing C, Gershoni-Baruch R, Ainsworth P, Daly M, Tung N, Eisen A, Olopade OI, Karlan B, Saal HM, Garber JE, Rennert G, Gilchrist D, Eng C, Offit K et al. (2006)
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers
8 (2), R15
DOI 10.1186/bcr1387, PubMed 16563180
Geirdal AØ, Maehle L, Heimdal K, Stormorken A, Møller P, Dahl AA (2006)
Quality of life and its relation to cancer-related stress in women of families with hereditary cancer without demonstrated mutation
15 (3), 461-70
DOI 10.1007/s11136-005-3008-3, PubMed 16547785
Møller P (2006)
[Increased incidence of testicular dysgenesis?]
126 (20), 2688; author reply 2688
PubMed 17057775
Møller P, Stormorken A, Apold J (2006)
[Handling of hereditary intestinal cancer]
126 (15), 1937-9
PubMed 16915319
Narod SA, Lubinski J, Ghadirian P, Lynch HT, Moller P, Foulkes WD, Rosen B, Kim-Sing C, Isaacs C, Domchek S, Sun P, Hereditary Breast Cancer Clinical Study Group (2006)
Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
7 (5), 402-6
DOI 10.1016/S1470-2045(06)70624-6, PubMed 16648044
Rudkin TM, Hamel N, Galvez M, Hogervorst F, Gille JJ, Møller P, Apold J, Foulkes WD (2006)
The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populations
7, 15
DOI 10.1186/1471-2350-7-15, PubMed 16509964
Rustad CF, Bjørnslett M, Heimdal KR, Mæhle L, Apold J, Møller P (2006)
Germline PTEN mutations are rare and highly penetrant
4 (4), 177-85
DOI 10.1186/1897-4287-4-4-177, PubMed 20223021
Stormorken A, Heintz KM, Andresen PA, Hovig E, Møller P (2006)
MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer
4 (2), 90-3
DOI 10.1186/1897-4287-4-2-90, PubMed 20223013
Stormorken AT, Hoff G, Norstein J, Bowitz-Lothe IM, Hanslien E, Grindedal E, Møller P (2006)
Estimated prevalence of hereditary cancers and the need for surveillance in a Norwegian county, Telemark
41 (1), 71-9
DOI 10.1080/00365520510023891, PubMed 16373279
Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, Weber B, Moller P, Offit K, Kim-Sing C, Friedman E, Randall S, Pasini B, Ainsworth P, Gershoni-Baruch R, Foulkes WD, Klijn J, Tung N, Rennert G, Olopade O, Couch F, Wagner T, Olsson H, Sun P, Weitzel JN et al. (2005)
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers
117 (6), 988-91
DOI 10.1002/ijc.21273, PubMed 15986445
Eisen A, Lubinski J, Klijn J, Moller P, Lynch HT, Offit K, Weber B, Rebbeck T, Neuhausen SL, Ghadirian P, Foulkes WD, Gershoni-Baruch R, Friedman E, Rennert G, Wagner T, Isaacs C, Kim-Sing C, Ainsworth P, Sun P, Narod SA (2005)
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study
23 (30), 7491-6
DOI 10.1200/JCO.2004.00.7138, PubMed 16234515
Geirdal AØ, Reichelt JG, Dahl AA, Heimdal K, Maehle L, Stormorken A, Møller P (2005)
Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations
4 (2), 121-6
DOI 10.1007/s10689-004-7995-y, PubMed 15951962
Hope Q, Bullock S, Evans C, Meitz J, Hamel N, Edwards SM, Severi G, Dearnaley D, Jhavar S, Southgate C, Falconer A, Dowe A, Muir K, Houlston RS, Engert JC, Roquis D, Sinnett D, Simard J, Heimdal K, Møller P, Maehle L, Badzioch M, Eeles RA, Easton DF, English DR et al. (2005)
Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer
14 (2), 397-402
DOI 10.1158/1055-9965.EPI-04-0202, PubMed 15734964
Kotsopoulos J, Lubinski J, Neuhausen SL, Lynch HT, Rosen B, Ainsworth P, Moller P, Ghadirian P, Isaacs C, Karlan B, Sun P, Narod SA (2005)
Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
100 (1), 83-8
DOI 10.1016/j.ygyno.2005.07.110, PubMed 16137751
Møller P (2005)
[Screening for hereditary hemochromatosis?]
125 (8), 1044-5; author reply 1045
PubMed 15852086
Møller P, Maehle L, Apold J (2005)
[Hereditary breast cancer]
125 (22), 3136-8
PubMed 16299574
Stormorken AT, Bowitz-Lothe IM, Norèn T, Kure E, Aase S, Wijnen J, Apold J, Heimdal K, Møller P (2005)
Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer
23 (21), 4705-12
DOI 10.1200/JCO.2005.05.180, PubMed 16034045
van der Klift H, Wijnen J, Wagner A, Verkuilen P, Tops C, Otway R, Kohonen-Corish M, Vasen H, Oliani C, Barana D, Moller P, Delozier-Blanchet C, Hutter P, Foulkes W, Lynch H, Burn J, Möslein G, Fodde R (2005)
Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC)
44 (2), 123-38
DOI 10.1002/gcc.20219, PubMed 15942939
Weitzel JN, Robson M, Pasini B, Manoukian S, Stoppa-Lyonnet D, Lynch HT, McLennan J, Foulkes WD, Wagner T, Tung N, Ghadirian P, Olopade O, Isaacs C, Kim-Sing C, Møller P, Neuhausen SL, Metcalfe K, Sun P, Narod SA (2005)
A comparison of bilateral breast cancers in BRCA carriers
14 (6), 1534-8
DOI 10.1158/1055-9965.EPI-05-0070, PubMed 15941968
Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Hsieh CL, Halpern J, Balise RN, Oakley-Girvan I, Whittemore AS et al. (2005)
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics
77 (2), 219-29
DOI 10.1086/432377, PubMed 15988677
Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F, Sandkuijl L, Møller P, Genuardi M, Van Houwelingen H, Tops C, Van Puijenbroek M, Verkuijlen P, Kenter G, Van Mil A, Meijers-Heijboer H, Tan GB, Breuning MH, Fodde R, Wijnen JT, Bröcker-Vriends AH, Vasen H (2004)
Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance
127 (1), 17-25
DOI 10.1053/j.gastro.2004.03.068, PubMed 15236168
Møller P, Apold J (2004)
[Retinoblastoma--hereditary eye cancer in children?]
124 (6), 830; author reply 830
PubMed 15039827
Reichelt JG, Heimdal K, Møller P, Dahl AA (2004)
BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample
3 (1), 21-8
DOI 10.1023/B:FAME.0000026820.32469.4a, PubMed 15131402
Bodd TL, Reichelt J, Heimdal K, Moller P (2003)
Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway
12 (5), 405-17
DOI 10.1023/a:1025864703405, PubMed 14758817
Jagmohan-Changur S, Poikonen T, Vilkki S, Launonen V, Wikman F, Orntoft TF, Møller P, Vasen H, Tops C, Kolodner RD, Mecklin JP, Järvinen H, Bevan S, Houlston RS, Aaltonen LA, Fodde R, Wijnen J, Karhu A (2003)
EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer
63 (1), 154-8
PubMed 12517792
Stormorken AT, Müller W, Lindblom A, Heimdal K, Aase S, Lothe IM, Norèn T, Wijnen JT, Möslein G, Møller P (2003)
The inframe MSH2 codon 596 deletion is linked with HNPCC and associated with lack of MSH2 protein in tumours
2 (1), 9-13
DOI 10.1023/a:1023362205205, PubMed 14574162
Heimdal K, Skovlund E, Møller P (2002)
Oral contraceptives and risk of familial breast cancer
26 (1), 23-7
DOI 10.1016/s0361-090x(02)00004-1, PubMed 12088199
Møller P, Borg A, Evans DG, Haites N, Reis MM, Vasen H, Anderson E, Steel CM, Apold J, Goudie D, Howell A, Lalloo F, Maehle L, Gregory H, Heimdal K (2002)
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy
101 (6), 555-9
DOI 10.1002/ijc.10641, PubMed 12237897
Narod SA, Dubé MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencher D, Heimdal K, Moller P, Robson M, Offit K, Isaacs C, Weber B, Friedman E, Gershoni-Baruch R, Rennert G, Pasini B, Wagner T, Daly M, Garber JE, Neuhausen SL, Ainsworth P, Olsson H, Evans G, Osborne M et al. (2002)
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
94 (23), 1773-9
DOI 10.1093/jnci/94.23.1773, PubMed 12464649
Østensen M, Møller P, Østensen H (1996)
Revmatisk sykdom og arvelighet: en pasientinformasjon
Haraldus Medical Communications, Trondheim, [6] bl.
BIBSYS 96111245x
Møller P (1984)
Genetic and clinical studies on Bechtherew's syndrome (hereditary multifocal relapsing inflammation)
P. Møller, Oslo, 1 b. (flere pag.)
BIBSYS 842055428, ISBN 82-90433-06-9
